A Case of Recurrent Cerebral Infarction During Treatment With Oral Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Clinical Neurology- Japan

doi 10.5692/clinicalneurol.cn-001222

Full Text

Abstract

Available in

Categories

Date

January 1, 2019

Authors

Masahiro Ebitani

Yukihiro Yaoita

Publisher

Societas Neurologica Japonica

Related search

Comparative Pharmacology of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

International Journal of Clinical Pharmacology & Pharmacotherapy

English

Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options

Clinical Lymphoma, Myeloma and Leukemia

Cancer Research

English

Comparison of Antitumor Effects of Multitargeted Tyrosine Kinase Inhibitors in Acute Myelogenous Leukemia

Molecular Cancer Therapeutics

Cancer Research

English

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

English

Management of Adverse Events Associated With Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Cancer Research

English

Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors

Klinicheskaya Onkogematologiya/Clinical Oncohematology

English

Complications of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia - Chronic Phase

Revista de Chimie

Materials Science

Materials Chemistry

English

Who 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors

Turkish Journal of Haematology

English

Future Perspectives of Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia

Chemotherapy: Open Access

English